Market News / Story
Haemonetics gains after update on CSL supply deal
Seeking Alpha ·
Seeking Alpha reports: Haemonetics added ~14% in the premarket on Thursday after announcing that, in line with a previously disclosed supply agreement, CSL Limited expects to deploy the company's devices throughout Australian biopharma's U.S. plasma collection centers by the end of 2027. Shares of Haemonetics rose after the blood management solutions provider disclosed the non-exclusive supply agreement with CSL Plasma in August. As part of the deal, CSL, which operates one of the world’s…